The following abstracts represent the oral presentations given at IWWM-12 (Prague-2024), Session 15: BTK-I Intolerant and Resistant Disease
Session Chairs: Carlos Fernández de Larrea Rodríguez, Prashant Kapoor
Dose reduction following ibrutinib intolerance in WM patients Sarosiek (USA)
Zanubrutinib for patient’s intolerant of prior BTK-I Shadman (USA)
Bortezomib for Patients Failing BTK-I Khwaja (UK)
BGB-16673 BTK Degrader Seymour (Australia)
Prague 2024 Conference Chairs
The Prague 2024 Scientific Committee members:
Ranjana Advani, MD (USA)
Xinxin Cao, MD (China)
Jorge Castillo, MD (USA)
Ramon Garcia Sanz, MD PhD (Spain)
Moshe Gatt, MD HMO (Israel)
Prashant Kapoor, MD (USA)
Efstathios Kastritis, MD (Greece)
M.J. Kersten, MD PhD AMC (NL)
Merav Leiba, MD (Israel)
Lugui Qiu, MD (China)
Naohiro Sekiguchi, MD, PhD (Japan)
Constantine Tam, MD, FRACP, FRCPA (Aus)
Alessandra Tedeschi, MD (Italy)
Judith Trotman, MD, FRACP, FRCPA (Aus)
Marzia Varettoni, MD (Italy)
Choose from the following list of Prague 2024 (IWWM-12) conference sessions:
Session 4: Single Cell RNA Analysis
Session 6: Molecular Diagnostics in WM
Session 9: Tumor Immune Microenvironment
Session 10: Chemoimmunotherapy in WM I
Session 11: Chemoimmunotherapy in WM II
Session 12: BTK-Inhibitors in WM I
Session 13: BTK-Inhibitors in WM II
Session 15: BTK-I Intolerant and Resistant Disease
Session 18: Special Topics Lectures
Session 19: Plenary Session II
Session 21: Novel Drug Development for WM
Session 22: Clinical Trials in Progress for WM I
Consensus Panel Reports from the 12th International Workshop on Waldenstrom's Macroglobulinemia
Consensus Panel 3 on the Management of Patients with High-Risk Disease
Consensus Panel 4 on the Management of Patients with non-IgM Lymphoplasmacytic Lymphoma
Consensus Panel 6 on Diagnosis and Management of Transformed Waldenstrom's Macroglobulinemia
New York 2018 Conference Chairs
The New York 2018 Scientific Committee members:
Ranjana Advani, MD (USA)
Jorge Castillo MD (USA)
Meletios Dimopoulos MD (Greece)
Ramón García-Sanz MD, PhD (Spain)
Zachary Hunter, PhD (USA)
Efstathios Kastritis, MD, PhD (Greece)
Marie Jóse Kersten MD, PhD (Netherlands)
Douglas E Joshua AM (Australia)
Véronique Leblond MD (France)
Giampaolo Merlini MD (Italy)
Roger Owen MD, MRCP, FRCPath (UK)
S.T. Pals, MD, PhD (Netherlands)
Marvin Stone, MD (USA)
Marzia Varretoni, MD (Italy)
Choose from the following list of New York 2018 (IWWM-10) conference sessions:
Session 1: Genomics in the Diagnosis and Management of WM
Session 2: Predisposition to WM
Session 3: Disease Presentation in WM
Session 4: Genomic Landscape of WM
Session 5: Mechanisms of Tumor Growth and Survival in WM
Session 6: Oral Presentations of Selected Abstracts I
Session 7: Rituximab-based Therapy
Session 8: Clinical Trial Updates in WM: Proteasome Inhibitors
Session 9: Clinical Trials Updates in WM: Ibrutinib
Session 10: Clinical Trials Updates in WM: Novel Agents and Trials in Progress
Session 11: Ibrutinib Resistance in WM
Session 12: Oral Presentations of Selected Abstracts II
Session 13: Specialized Treatment Approaches to WM
Session 15: Associated and Secondary Malignancy Risks in WM Patients
New York 2018 (IWWM-10) was held at the New York Marriott Downtown in New York City.
Please select the gallery to be viewed.
Madrid 2022 Conference Chairs
The Madrid 2022 Scientific Committee members:
Ranjana Advani, MD (USA)
Jorge Castillo, MD (USA)
Christian Buske MD, PhD (Germany)
Shirley D’Sa, MD, FRCPath (UK)
Meletios Dimopoulos, MD (Greece)
Zachary Hunter, PhD (USA)
Efstathios Kastritis, MD, PhD (Greece)
Marie Jóse Kersten, MD, PhD (Netherlands)
Véronique Leblond, MD (France)
Roger Owen MD, MRCP, FRCPath (UK)
Bruno Paiva, PhD (Spain)
M. Lia Palomba, MD (USA)
Constantine Tam, MD, FRACP, FRCPA (Australia)
Alessandra Tedeschi, MD (Italy)
Judith Trotman, MD, FRACP, FRCPA (Australia)
Marzia Varettoni, MD (Italy)
The Madrid 2022 Young Investigator Award Winners:
Patrizia Mondello, MD, PhD, MSc
Karan Lal Chohan, MD
Melanie Khamyath
Alexandros Gkiokas, MD, MSc
David F. Moreno, MD
Vaishali Bhardwaj, PhD
Joshua Gustine, MPH
Jahanzaib Khwaja
Martina Ferrante
Quentin Lemasson
The Madrid 2022 (IWWM-11) Consensus Panel Reports:
Consensus Panel 1 on Management of Symptomatic, Treatment-Naïve Patients
Consensus Panel 2 on the Management of Relapsed or Refractory WM Patients
Consensus Panel 3 on Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia
Consensus Panel 4 on Diagnostic and Response Criteria
Consensus Panel 5 on COVID-19 Prophylaxis and Management
Consensus Panel 6 on Management of Waldenström's Macroglobulinemia Related Amyloidosis
Consensus Panel 7 on Priorities for Novel Clinical Trials.: Clinical Trial Priorities for WM
Please select the gallery to be viewed.
Amsterdam 2016 Organizers
The Amsterdam 2016 Scientific Committee members:
Stephen Ansell MD, PhD (USA)
Christian Buske MD, PhD (Germany)
Jorge Castillo MD (USA)
Meletios Dimopoulos MD (Greece)
Ramón García-Sanz MD, PhD (Spain)
Marie Jóse Kersten MD, PhD (Netherlands)
Douglas E Joshua AM (Australia)
Véronique Leblond MD (France)
Xavier Leleu MD, PhD (France)
Mary McMaster MD, PhD (USA)
Giampaolo Merlini MD (Italy)
Monique Minnema MD, PhD (Netherlands)
Enrica Morra MD (Italy)
Roger Owen MD, MRCP, FRCPath (UK)
S.T. Pals, MD, PhD (Netherlands)
Linda Pilarski PhD (Canada)
Steven Treon MD PhD (USA)
Click here to download the preliminary program agenda for the 9th International Workshop on WM (IWWM-9).
Click here to display the sponsors for the 9th International Workshop on WM (IWWM-9).
Choose from the following list of IWWM-9 (Amsterdam 2016) conference sessions:
Symposium on Advances in Multiple Myeloma
Session 1: Diagnostic Workup of WM
Session 2: Predisposition in WM
Session 3: Malignant Transformation in WM
Session 4: Genomic Landscape in WM
Session 6: Keynote Lectures: Myddosome Signaling: What have we learned?
Session 7: CXCR4 WHIM mutations and WM Pathogenesis
Session 8: Non-MYD88 and CXCR4 Signaling in WM
Session 9: BTK directed Therapy in WM
Session 10: Short Oral Discussion of Selected Poster Abstracts
Session 11: Novel Therapeutic approaches for WM
Session 12: Great Debate I - What should be the frontline standard for treatment of WM?
Session 12: Great Debate II - What should be the goal of therapy in 2017 for WM patients?
Session 13: Management of Specific Disease Morbidities in WM (Part 1)
Session 14: Management of Specific Disease Morbidities in WM (Part 2)
Session 15: Discussion: When should autologous transplant be offered to WM patients?
Registration is closed for this event.
Amsterdam 2016 (IWWM-9) was held at the Renaissance Hotel in Amsterdam.
Please enjoy this interactive sightseeing map of Amsterdam:
Please select the gallery to be viewed. Special thanks to Roger Brown (WMUK) and Bob Manning (Bing Ctr) for contributing to the photos.
The following slide presentations given at the Doctor-Patient Forum can be viewed by clicking the desired presentation:
About the IWMF Carl Harrington
WM Diagnostics, Symptoms, & Treatment Criteria Ramon Garcia-Sanz
Predispositions: Familial & Secondary Cancers Robert Kyle
Biomarkers & Genomic Targets: MYD88 & CXCR4 Zachary Hunter
Disease Morbidities I: PN, Bing-Neel, Renal Monique Minnema
Upfront Treatment Approaches Jorge Castillo
Relapsed Refractory Approaches MJ Kersten
Disease Morbidities II: Amyloid, IgM Related Disorders, Hyperviscosity and Cryos Josephine Vos
Self-Management: Fitness, Supplements, Diet & Fatigue Toni Dubeau
Copyright © 2026 International Waldenström's Macroglobulinemia Workshops. All Rights Reserved.